BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27834155)

  • 1. Whole-genome fetal and maternal DNA methylation analysis using MeDIP-NGS for the identification of differentially methylated regions.
    Keravnou A; Ioannides M; Tsangaras K; Loizides C; Hadjidaniel MD; Papageorgiou EA; Kyriakou S; Antoniou P; Mina P; Achilleos A; Neofytou M; Kypri E; Sismani C; Koumbaris G; Patsalis PC
    Genet Res (Camb); 2016 Nov; 98():e15. PubMed ID: 27834155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylome profiling of maternal peripheral blood and placentas reveal potential fetal DNA markers for non-invasive prenatal testing.
    Xiang Y; Zhang J; Li Q; Zhou X; Wang T; Xu M; Xia S; Xing Q; Wang L; He L; Zhao X
    Mol Hum Reprod; 2014 Sep; 20(9):875-84. PubMed ID: 24996894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MeDIP combined with in-solution targeted enrichment followed by NGS: Inter-individual methylation variability of fetal-specific biomarkers and their implementation in a proof of concept study for NIPT.
    Keravnou A; Ioannides M; Loizides C; Tsangaras K; Achilleos A; Mina P; Kypri E; Hadjidaniel MD; Neofytou M; Kyriacou S; Sismani C; Koumbaris G; Patsalis PC
    PLoS One; 2018; 13(6):e0199010. PubMed ID: 29889893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-individual methylation variability in differentially methylated regions between maternal whole blood and first trimester CVS.
    Ioannides M; Papageorgiou EA; Keravnou A; Tsaliki E; Spyrou C; Hadjidaniel M; Sismani C; Koumbaris G; Patsalis PC
    Mol Cytogenet; 2014; 7(1):73. PubMed ID: 25426166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of epigenetic biomarkers for the noninvasive diagnosis of fetal disease.
    Bunce K; Chu T; Surti U; Hogge WA; Peters DG
    Prenat Diagn; 2012 Jun; 32(6):542-9. PubMed ID: 22495992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing.
    Gordevičius J; Narmontė M; Gibas P; Kvederavičiūtė K; Tomkutė V; Paluoja P; Krjutškov K; Salumets A; Kriukienė E
    Clin Epigenetics; 2020 Oct; 12(1):153. PubMed ID: 33081811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of ffDNA in maternal plasma does not prevent correct classification of trisomy 21 using MeDIP-qPCR methodology.
    Kyriakou S; Kypri E; Spyrou C; Tsaliki E; Velissariou V; Papageorgiou EA; Patsalis PC
    Prenat Diagn; 2013 Jul; 33(7):650-5. PubMed ID: 23619923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA.
    Lun FM; Chiu RW; Sun K; Leung TY; Jiang P; Chan KC; Sun H; Lo YM
    Clin Chem; 2013 Nov; 59(11):1583-94. PubMed ID: 23857673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially methylated HpaII sites by NGS analysis of HpaII-digested libraries.
    Tanaka S; Hayakawa Y; Kawashima A; Goto M; Matusoka R; Sekizawa A; Gotoh K
    Anal Biochem; 2020 Nov; 609():113977. PubMed ID: 33010204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of methylomic and transcriptomic data in fetal sheep muscle tissues in response to maternal diet during pregnancy.
    Namous H; Peñagaricano F; Del Corvo M; Capra E; Thomas DL; Stella A; Williams JL; Marsan PA; Khatib H
    BMC Genomics; 2018 Feb; 19(1):123. PubMed ID: 29409445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenome-wide DNA methylation assay reveals placental epigenetic markers for noninvasive fetal single-nucleotide polymorphism genotyping in maternal plasma.
    Ou X; Wang H; Qu D; Chen Y; Gao J; Sun H
    Transfusion; 2014 Oct; 54(10):2523-33. PubMed ID: 24749853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole genome bisulfite sequencing of cell-free DNA and its cellular contributors uncovers placenta hypomethylated domains.
    Jensen TJ; Kim SK; Zhu Z; Chin C; Gebhard C; Lu T; Deciu C; van den Boom D; Ehrich M
    Genome Biol; 2015 Apr; 16(1):78. PubMed ID: 25886572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome.
    Tsui DW; Lam YM; Lee WS; Leung TY; Lau TK; Lau ET; Tang MH; Akolekar R; Nicolaides KH; Chiu RW; Lo YM; Chim SS
    PLoS One; 2010 Nov; 5(11):e15069. PubMed ID: 21152411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray-Based Analysis of Methylation Status of CpGs in Placental DNA and Maternal Blood DNA--Potential New Epigenetic Biomarkers for Cell Free Fetal DNA-Based Diagnosis.
    Hatt L; Aagaard MM; Graakjaer J; Bach C; Sommer S; Agerholm IE; Kølvraa S; Bojesen A
    PLoS One; 2015; 10(7):e0128918. PubMed ID: 26230497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prematurity on genome wide methylation in the placenta.
    Schuster J; Uzun A; Stablia J; Schorl C; Mori M; Padbury JF
    BMC Med Genet; 2019 Jun; 20(1):116. PubMed ID: 31253109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method for non-invasive prenatal diagnosis of Down syndrome using MeDIP real time qPCR.
    Patsalis PC
    Appl Transl Genom; 2012 Dec; 1():3-8. PubMed ID: 27896047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome.
    Old RW; Crea F; Puszyk W; Hultén MA
    Reprod Biomed Online; 2007 Aug; 15(2):227-35. PubMed ID: 17697502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisulfite Conversion of DNA: Performance Comparison of Different Kits and Methylation Quantitation of Epigenetic Biomarkers that Have the Potential to Be Used in Non-Invasive Prenatal Testing.
    Leontiou CA; Hadjidaniel MD; Mina P; Antoniou P; Ioannides M; Patsalis PC
    PLoS One; 2015; 10(8):e0135058. PubMed ID: 26247357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease.
    Chu T; Burke B; Bunce K; Surti U; Allen Hogge W; Peters DG
    Prenat Diagn; 2009 Nov; 29(11):1020-30. PubMed ID: 19650061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a new methylation-based fetal fraction estimation assay using multiplex ddPCR.
    Ioannides M; Achilleos A; Kyriakou S; Kypri E; Loizides C; Tsangaras K; Constantinou L; Koumbaris G; Patsalis PC
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1094. PubMed ID: 31821748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.